2021 Program
Scientific Agenda & Speakers
FRIDAY JUNE 11, 2021
09h00 Welcome & Opening Remarks Peter Dicpinigaitis
09h05 Updates on Cough Guidelines Chair: Peter Dicpinigaitis
Highlights of the 2020 ERS Cough Management Guidelines Alyn Morice
09h25 Q&A
09h30 Pediatric updates in the CHEST cough guidelines Anne Chang
09h50 Q&A
09h55 BREAK
10h00 Issues in Cough Clinical Trials Chair: Surinder Birring
The placebo effect in cough & its relevance to antitussive clinical trials Ron Eccles
10h20 Q&A
10h25 The ideal antitussive trial design Surinder Birring
10:45 Q&A
10h50 Developing a consumer technology-based automated cough counter L. Cesnakova
11h10 Q&A
11h15 BREAK
11h30 Insights into Mechanisms of Cough Chairs: K. Fan Chung, I. Satia
CNS mechanisms regulating cough in health and disease Stuart Mazzone
11h50 Q&A
11h55 Chemosensory brush cell regulation of the cough reflex Brendan Canning
12h15 Q&A
12h20 Mechanisms of cough in asthma & non-asthmatic eosinophilic bronchitis Imran Satia
12h40 Q&A
12h45 Post-COVID-19 chronic cough: assessment 18-months into the pandemic Woo-Jung Song
13h05 Q&A
13h10 LUNCH BREAK
14h15 Issues in Clinical Cough Management Chairs: Alyn Morice, Peter Dicpinigaitis
Precision medicine approaches to diagnosis and management of RCC Jacky Smith
14h35 Q&A
14h40 The role of the Speech-Language Pathologist in the evaluation and
management of chronic cough Laurie Slovarp
15h00 Q&A
15h05 The journey of the chronic cough patient: repetitive physician visits, and
churn through the system Heikki Koskela
15h25 Q&A
15h30 Refractory Chronic Cough: What should we do now while we await the first
antitussive drug approval? K. Fan Chung
15h50 Q&A
16h00 Close of Day
PLEASE NOTE ALL TIMES ARE EDT (US Eastern)
Saturday June 12, 2021
09h00
Opening Remarks & Day 1 Recap Peter Dicpinigaitis
Update on Antitussive Clinical Trials - P2X3 antagonists Chairs: C. Page, J. Smith
09h15 Gefapixant Carmen La Rosa
09h35 Q&A
09h40 BLU-5937 Catherine Bonuccelli
10h00 Q&A
10h05 Updates on BAY 1817080 and BAY 190260 Melanie Wosnitza
10h25 Q&A
10h30 S-600918 Yuko Matsunaga
10h50 Q&A
10h55
Break
11h10
Update on Other Antitussive Clinical Trials Chair: Brendan Canning
NaV1.7 voltage-gated sodium channel blockers as antitussives
11h15 Nocion – NOC 100 (NTX-1175) Rick Batycky
11h35 Q&A
11h40 SiteOne John Hunter
12h00 Q&A
12h05 Update on NK-1-Receptor Antagonist Clinical Trials
NeRRe - Orvepitant Steve Pawsey
12h25 Q&A
12h30
Lunch Break
13h00
Oral Abstracts Chairs: Peter Dicpinigaitis, Jacky Smith
1. Guaifenesin Modifies Airway Mucus, Reduces Mucus-Cell Surface
Interactions, and Increases Mucociliary Transport in an Organotypic
In Vitro Model Phillip Clapp
2. Effects of Severity of Laryngeal Sensations on Cough-Related
Quality of Life Haruhiko Ogawa
3. A Mouse Model of Infectious Viral Cough Edward T. Wei
4. The Clinical Utility of Laryngoscopy in the Management of Chronic
Cough and Vocal Cord Dysfunction Anne E. Vertigan
5. Programmatic Desensitization of the Cough Reflex in Patients with
Refractory Chronic Cough Laurie Slovarp
6. Comparison of the Capsaicin-Evoked Cough Responses with Histamine-
Induced Itch and Wheal Responses in Atopic Asthma Hafsa Omer
7. Anxiety as a Factor in Treatment Outcomes for Chronic
Refractory Cough Miranda L. Wright
8. A Speech Obfuscation Algorithm for Data Privacy in 24-Hour Audio
Based Cough Monitoring Terence E. Taylor
9. An Artificial Intelligence Algorithm-Based Smartphone Application
Can Help To Monitor Cough In Real-Time Mandel Sher
15h00